NATASHA TATE: Open Payments
NPI 1013493840 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 70 payments from 24 companies in 2025. Trend: 2023 $1,994 · 2024 $2,011 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $270 |
| Amgen Inc. | 12 | $171 |
| Medtronic, Inc. | 1 | $147 |
| Boston Scientific Corporation | 5 | $124 |
| PFIZER INC. | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 6 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Corcept Therapeutics | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Saluda Medical Americas, Inc. | 2 | $63 |
Products named: Ozempic, REPATHA, PERCEPTA QUAD CRT-P MRI SURESCAN, ELIQUIS, JARDIANCE, Korlym, CAMZYOS, CAPLYTA.
Industry payments across FL — which companies pay providers there.
